DU
GOSS icon

Delphia (USA)’s Gossamer Bio GOSS Stock Holding History

Delphia (USA)’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-149
Closed -$100K – 340
2022
Q2 		$100K Buy
+149
New +$92.4K 0.07% 338

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Delphia (USA)'s GOSS Position: Q3 2022 in Review

Delphia (USA) sold out of Gossamer Bio (GOSS) in Q3 2022, closing a stake of 149 shares — an estimated $100K sold.

Delphia (USA) first reported a position in GOSS in Q2 2022 and held it in 1 quarter. The position peaked at $100K in Q2 2022. 157 funds tracked by Wall St. Rank hold GOSS as of Q3 2022.

  • Delphia (USA) reported no remaining Gossamer Bio position as of Q3 2022 after selling out during the quarter.
  • Delphia (USA) sold 149 Gossamer Bio shares in Q3 2022, an estimated $100K.
  • Delphia (USA) first reported a position in Gossamer Bio in Q2 2022 and held it in 1 quarter.
  • Delphia (USA)'s Gossamer Bio position peaked at $100K in Q2 2022.
  • 157 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2022.

Based on Delphia (USA)'s 13F filing for Q3 2022, filed 14 Nov 2022.